BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

620 related articles for article (PubMed ID: 10525530)

  • 1. PML is critical for ND10 formation and recruits the PML-interacting protein daxx to this nuclear structure when modified by SUMO-1.
    Ishov AM; Sotnikov AG; Negorev D; Vladimirova OV; Neff N; Kamitani T; Yeh ET; Strauss JF; Maul GG
    J Cell Biol; 1999 Oct; 147(2):221-34. PubMed ID: 10525530
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Review: properties and assembly mechanisms of ND10, PML bodies, or PODs.
    Maul GG; Negorev D; Bell P; Ishov AM
    J Struct Biol; 2000 Apr; 129(2-3):278-87. PubMed ID: 10806078
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The homeodomain-interacting kinase PKM (HIPK-2) modifies ND10 through both its kinase domain and a SUMO-1 interaction motif and alters the posttranslational modification of PML.
    Engelhardt OG; Boutell C; Orr A; Ullrich E; Haller O; Everett RD
    Exp Cell Res; 2003 Feb; 283(1):36-50. PubMed ID: 12565818
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock and Cd2+ exposure regulate PML and Daxx release from ND10 by independent mechanisms that modify the induction of heat-shock proteins 70 and 25 differently.
    Nefkens I; Negorev DG; Ishov AM; Michaelson JS; Yeh ET; Tanguay RM; Müller WE; Maul GG
    J Cell Sci; 2003 Feb; 116(Pt 3):513-24. PubMed ID: 12508112
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis delta virus replication generates complexes of large hepatitis delta antigen and antigenomic RNA that affiliate with and alter nuclear domain 10.
    Bell P; Brazas R; Ganem D; Maul GG
    J Virol; 2000 Jun; 74(11):5329-36. PubMed ID: 10799610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Nuclear localization but not PML protein is required for incorporation of the papillomavirus minor capsid protein L2 into virus-like particles.
    Becker KA; Florin L; Sapp C; Maul GG; Sapp M
    J Virol; 2004 Feb; 78(3):1121-8. PubMed ID: 14722267
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Interferon-induced antiviral Mx1 GTPase is associated with components of the SUMO-1 system and promyelocytic leukemia protein nuclear bodies.
    Engelhardt OG; Ullrich E; Kochs G; Haller O
    Exp Cell Res; 2001 Dec; 271(2):286-95. PubMed ID: 11716541
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for separate ND10-binding and homo-oligomerization domains of Sp100.
    Negorev D; Ishov AM; Maul GG
    J Cell Sci; 2001 Jan; 114(Pt 1):59-68. PubMed ID: 11112690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of Daxx interacting with p73, one of the p53 family, and its regulation of p53 activity by competitive interaction with PML.
    Kim EJ; Park JS; Um SJ
    Nucleic Acids Res; 2003 Sep; 31(18):5356-67. PubMed ID: 12954772
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role of SUMO-1-modified PML in nuclear body formation.
    Zhong S; Müller S; Ronchetti S; Freemont PS; Dejean A; Pandolfi PP
    Blood; 2000 May; 95(9):2748-52. PubMed ID: 10779416
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Heterochromatin and ND10 are cell-cycle regulated and phosphorylation-dependent alternate nuclear sites of the transcription repressor Daxx and SWI/SNF protein ATRX.
    Ishov AM; Vladimirova OV; Maul GG
    J Cell Sci; 2004 Aug; 117(Pt 17):3807-20. PubMed ID: 15252119
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Pax3 transcriptional activity by SUMO-1-modified PML.
    Lehembre F; Müller S; Pandolfi PP; Dejean A
    Oncogene; 2001 Jan; 20(1):1-9. PubMed ID: 11244500
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Overexpression of promyelocytic leukemia protein precludes the dispersal of ND10 structures and has no effect on accumulation of infectious herpes simplex virus 1 or its proteins.
    Lopez P; Jacob RJ; Roizman B
    J Virol; 2002 Sep; 76(18):9355-67. PubMed ID: 12186918
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of SUMO-interacting motif in Daxx SUMO modification, subnuclear localization, and repression of sumoylated transcription factors.
    Lin DY; Huang YS; Jeng JC; Kuo HY; Chang CC; Chao TT; Ho CC; Chen YC; Lin TP; Fang HI; Hung CC; Suen CS; Hwang MJ; Chang KS; Maul GG; Shih HM
    Mol Cell; 2006 Nov; 24(3):341-54. PubMed ID: 17081986
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Modification of nuclear PML protein by SUMO-1 regulates Fas-induced apoptosis in rheumatoid arthritis synovial fibroblasts.
    Meinecke I; Cinski A; Baier A; Peters MA; Dankbar B; Wille A; Drynda A; Mendoza H; Gay RE; Hay RT; Ink B; Gay S; Pap T
    Proc Natl Acad Sci U S A; 2007 Mar; 104(12):5073-8. PubMed ID: 17360386
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evidence for covalent modification of the nuclear dot-associated proteins PML and Sp100 by PIC1/SUMO-1.
    Sternsdorf T; Jensen K; Will H
    J Cell Biol; 1997 Dec; 139(7):1621-34. PubMed ID: 9412458
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Daxx-mediated accumulation of human cytomegalovirus tegument protein pp71 at ND10 facilitates initiation of viral infection at these nuclear domains.
    Ishov AM; Vladimirova OV; Maul GG
    J Virol; 2002 Aug; 76(15):7705-12. PubMed ID: 12097584
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sequestration and inhibition of Daxx-mediated transcriptional repression by PML.
    Li H; Leo C; Zhu J; Wu X; O'Neil J; Park EJ; Chen JD
    Mol Cell Biol; 2000 Mar; 20(5):1784-96. PubMed ID: 10669754
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies against protein Daxx and its localization in nuclear domains 10].
    Sotnikov AG; Negorev D; Ishov AM; Maul GG
    Tsitologiia; 2001; 43(12):1123-9. PubMed ID: 11881150
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Viral FGARAT Homolog ORF75 of Rhesus Monkey Rhadinovirus Effects Proteasomal Degradation of the ND10 Components SP100 and PML.
    Hahn AS; Großkopf AK; Jungnickl D; Scholz B; Ensser A
    J Virol; 2016 Sep; 90(17):8013-28. PubMed ID: 27356898
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.